Although expression of CA-CaMKII did not induce leukemia development on its own, increased CaMKII activity was associated with new progression to hematologic malignancy on a tp53 predisposition background, indicating it functions as an additional “hit” during transformation. Here, CAMK2G is linked to leukemia.